Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STASH II: 7-Day vs 14-Day Corticosteroid in Severe Alcohol-Associated Hepatitis
NCT06919458Phase 3Completed
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Apr 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in alcoholic hepatitis (AH), sponsored by Asian Institute of Gastroenterology. Started Apr 2025; status: completed.
02
Drugs
prednisolone
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT06919458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919458.